Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers

Qub ai Hu, Mark G. Hearn, Lee-Way Jin, Steven L. Bressler, George M. Martin

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

FE65 is predominantly expressed in brain and is especially rich in the regions with the highest densities of neurons. The FE65 protein binds to an intracellular domain of the β-amyloid precursor protein (βPP) and may modulate the production of β-amyloid peptide (AP). One of FE65 exons, a mini-exon (exon 9, 6 bp), is alternatively spliced, giving rise to two isoforms varying only in 6 base pairs. We quantitated the two isoforms by a sensitive reverse transcription-competitive polymerase chain reaction technique, and characterized their expressions in various tissues and cell cultures, and the kinetics of expression of the two isoforms in P19 embryonal carcinoma cell lines during neuronal differentiation. Our results show that the exon 9-inclusive (E9) form, the more abundant form in brain, was exclusively expressed in neurons, while the exon 9-exclusive (AE9) form was widely expressed in all non-neuronal cells, but was not expressed in differentiated neurons. When P19 cells were differentiated to neurons, expression of rE65 was significantly up regulated (~30-fold) and the splicing pattern of the rE65 pre-mRNA was switched from the AE9 pattern to the E9 form. Based upon their distinctive expression patterns, these two isoforms may serve as neuronal and non-neuronal markers, and determination of their ratios may have applications in neuropathological diagnosis.

Original languageEnglish (US)
Pages (from-to)632-640
Number of pages9
JournalJournal of Neuroscience Research
Volume58
Issue number5
DOIs
StatePublished - Dec 1 1999
Externally publishedYes

Fingerprint

Exons
Protein Isoforms
Neurons
Embryonal Carcinoma Stem Cells
Amyloid beta-Protein Precursor
RNA Precursors
Brain
Amyloid
Base Pairing
Reverse Transcription
Cell Culture Techniques
Cell Line
Polymerase Chain Reaction
Peptides
Proteins

Keywords

  • Alternative splicing
  • Alzheimer's disease
  • Neuronal marker
  • Quantitative RT- PCR
  • RE65

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers. / Hu, Qub ai; Hearn, Mark G.; Jin, Lee-Way; Bressler, Steven L.; Martin, George M.

In: Journal of Neuroscience Research, Vol. 58, No. 5, 01.12.1999, p. 632-640.

Research output: Contribution to journalArticle

Hu, Qub ai ; Hearn, Mark G. ; Jin, Lee-Way ; Bressler, Steven L. ; Martin, George M. / Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers. In: Journal of Neuroscience Research. 1999 ; Vol. 58, No. 5. pp. 632-640.
@article{965d361ebb184aeba9199df0bc247f82,
title = "Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers",
abstract = "FE65 is predominantly expressed in brain and is especially rich in the regions with the highest densities of neurons. The FE65 protein binds to an intracellular domain of the β-amyloid precursor protein (βPP) and may modulate the production of β-amyloid peptide (AP). One of FE65 exons, a mini-exon (exon 9, 6 bp), is alternatively spliced, giving rise to two isoforms varying only in 6 base pairs. We quantitated the two isoforms by a sensitive reverse transcription-competitive polymerase chain reaction technique, and characterized their expressions in various tissues and cell cultures, and the kinetics of expression of the two isoforms in P19 embryonal carcinoma cell lines during neuronal differentiation. Our results show that the exon 9-inclusive (E9) form, the more abundant form in brain, was exclusively expressed in neurons, while the exon 9-exclusive (AE9) form was widely expressed in all non-neuronal cells, but was not expressed in differentiated neurons. When P19 cells were differentiated to neurons, expression of rE65 was significantly up regulated (~30-fold) and the splicing pattern of the rE65 pre-mRNA was switched from the AE9 pattern to the E9 form. Based upon their distinctive expression patterns, these two isoforms may serve as neuronal and non-neuronal markers, and determination of their ratios may have applications in neuropathological diagnosis.",
keywords = "Alternative splicing, Alzheimer's disease, Neuronal marker, Quantitative RT- PCR, RE65",
author = "Hu, {Qub ai} and Hearn, {Mark G.} and Lee-Way Jin and Bressler, {Steven L.} and Martin, {George M.}",
year = "1999",
month = "12",
day = "1",
doi = "10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P",
language = "English (US)",
volume = "58",
pages = "632--640",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers

AU - Hu, Qub ai

AU - Hearn, Mark G.

AU - Jin, Lee-Way

AU - Bressler, Steven L.

AU - Martin, George M.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - FE65 is predominantly expressed in brain and is especially rich in the regions with the highest densities of neurons. The FE65 protein binds to an intracellular domain of the β-amyloid precursor protein (βPP) and may modulate the production of β-amyloid peptide (AP). One of FE65 exons, a mini-exon (exon 9, 6 bp), is alternatively spliced, giving rise to two isoforms varying only in 6 base pairs. We quantitated the two isoforms by a sensitive reverse transcription-competitive polymerase chain reaction technique, and characterized their expressions in various tissues and cell cultures, and the kinetics of expression of the two isoforms in P19 embryonal carcinoma cell lines during neuronal differentiation. Our results show that the exon 9-inclusive (E9) form, the more abundant form in brain, was exclusively expressed in neurons, while the exon 9-exclusive (AE9) form was widely expressed in all non-neuronal cells, but was not expressed in differentiated neurons. When P19 cells were differentiated to neurons, expression of rE65 was significantly up regulated (~30-fold) and the splicing pattern of the rE65 pre-mRNA was switched from the AE9 pattern to the E9 form. Based upon their distinctive expression patterns, these two isoforms may serve as neuronal and non-neuronal markers, and determination of their ratios may have applications in neuropathological diagnosis.

AB - FE65 is predominantly expressed in brain and is especially rich in the regions with the highest densities of neurons. The FE65 protein binds to an intracellular domain of the β-amyloid precursor protein (βPP) and may modulate the production of β-amyloid peptide (AP). One of FE65 exons, a mini-exon (exon 9, 6 bp), is alternatively spliced, giving rise to two isoforms varying only in 6 base pairs. We quantitated the two isoforms by a sensitive reverse transcription-competitive polymerase chain reaction technique, and characterized their expressions in various tissues and cell cultures, and the kinetics of expression of the two isoforms in P19 embryonal carcinoma cell lines during neuronal differentiation. Our results show that the exon 9-inclusive (E9) form, the more abundant form in brain, was exclusively expressed in neurons, while the exon 9-exclusive (AE9) form was widely expressed in all non-neuronal cells, but was not expressed in differentiated neurons. When P19 cells were differentiated to neurons, expression of rE65 was significantly up regulated (~30-fold) and the splicing pattern of the rE65 pre-mRNA was switched from the AE9 pattern to the E9 form. Based upon their distinctive expression patterns, these two isoforms may serve as neuronal and non-neuronal markers, and determination of their ratios may have applications in neuropathological diagnosis.

KW - Alternative splicing

KW - Alzheimer's disease

KW - Neuronal marker

KW - Quantitative RT- PCR

KW - RE65

UR - http://www.scopus.com/inward/record.url?scp=0033485891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033485891&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P

DO - 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P

M3 - Article

C2 - 10561691

AN - SCOPUS:0033485891

VL - 58

SP - 632

EP - 640

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 5

ER -